DrugsControl Media Services
DrugsControl.org

News Detail

US FDA approves First Drug Indicated in Patients with WHIM Syndrome (30-04-2024)

BOSTON, 30 APRIL 2024 (GLOBE NEWSWIRE) X4 Pharmaceuticals View Details

Source : GLOBE NEWSWIRE
X4 Pharmaceuticals XOLREMDI™ (mavorixafor) WHIM syndrome (warts hypogammaglobulinemia infections and myelokathexis) U.S. Food and Drug Administration (FDA)

Related News